Updated Data Matrix Available

Market Value | Market Volume | Epidemiology | Clinical Trials | Patent Landscape | Regulatory Approvals

Global Intravascular Ultrasound (IVUS) Devices Market $1.2 Billion by 2031

The global market for intravascular ultrasound (IVUS) devices estimated to reach $1.2 billion by 2031, growing steadily at a CAGR of 4.9% over the forecast period, driven by increasing prevalence and incidence of cardiovascular diseases, and being the first catheter-based imaging modality that has been widely used in interventional cardiology.

  • Other factors driving market growth include growing demand and wider adoption of diagnostic cardiovascular imaging devices for advanced and accurate medical imaging, as well as increased diagnostic confidence and workflow effectiveness across the world.
Global Intravascular Ultrasound (IVUS) Devices Market

Intravascular ultrasound (IVUS) is an intravascular imaging modality primarily used in interventional cardiology to characterize lesion morphology, quantify plaque burden, guide stent sizing, assess stent expansion, and identify procedural complications. IVUS is a widely used imaging modality providing complementary diagnostic information to angiography regarding the vessel wall of the coronary arteries. IVUS has been used for assessment of ambiguous angiographic lesions, evaluation of new interventional devices and in atherosclerosis progression-regression trials.

  • However, the standard grayscale IVUS has limited value for the accurate identification of specific plaque components. This limitation has been partially over- come by introduction of new IVUS-based imaging methods such as: virtual histology IVUS, iMAP-IVUS and Integrated Backscatter IVUS.
    • These methods utilize the ultrasound backscatter signal to enable a more detailed characterization of plaque morphology or tissue characterization and to provide insight on the features of vulnerable plaque.
      • IVUS has also been used to evaluate new interventional devices and for atherosclerosis progression-regression trials. Recently, IVUS has been used to detect vulnerable plaques. The IVUS can overcome the intrinsic limitations of coronary angiography for lesion assessment and stenting. IVUS improves outcomes of patients presenting with stable or complex coronary artery disease.
        • The IVUS guidance during percutaneous coronary intervention (PCI) offers tomographic images of the coronary vessels, allowing optimization of stent implantation at the time of PCI.

The global market for intravascular ultrasound devices research report provides market size ($million 2021 to 2031), market share analysis, growth trends and forecast (CAGR%, 2024 to 2031).

The global market for intravascular ultrasound devices market segmented by modality (iMAP IVUS, virtual histology IVUS, integrated backscatter IVUS), product [consoles, accessories (catheters, guidewires, others)], end user (hospitals, diagnostic imaging centers, academic and research institutes), and geography.

  • Based on the modalities, the virtual histology IVUS segment accounted for the largest share of the total intravascular ultrasound market, owing to being the most widely used traditional method.
    • Virtual histology (VH) IVUS based on the spectral analysis of the raw backscattered IVUS radiofrequency data.
      • It utilizes a mathematical autoregressive model and constructs tissue maps that classify plaque into four major tissue types (fibrous, fibro-fatty, necrotic core, and dense calcium).
      • VH-IVUS clinical utility ranges from predicting high-risk plaques for patients undergoing coronary angiography to predicting adverse events post PCI.
  • On the other hand, the iMAP IVUS modality segment expected to register the fastest growth rate during the next five years period.
    • Unlike VH-IVUS, iMap uses a 40 MHz single rotational transducer and can acquire radiofrequency data continuously.
    • iMAP can be used for the in vivo identification of vulnerable plaque and prediction of adverse events of PCI.
    • iMAP-IVUS has been used to evaluate neointimal tissue components after stent implantation.
  • Among the end users, the hospitals segment held the largest revenue share of the global intravascular ultrasound systems market, while the diagnostic imaging centers segment expected to witness the fastest growth rate throughout the forecast period.

The global market for intravascular ultrasound systems research report is further segmented by geography into North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), Latin America (Brazil, Mexico, Rest of LA), and Rest of the World.

  • In terms of geography, the North America region dominated the global market for intravascular ultrasound products market, followed by the Europe region, mainly attributed to increasing incidence of cardiac diseases, rising adoption of ultrasound diagnostic imaging in primary healthcare settings, greater healthcare spending in developed countries, and effective reimbursement policies.
    • For example, atherosclerosis is the leading cause of cardiovascular mortality and morbidity in the developed world.
  • However, the Asia Pacific region anticipated to be the most attractive market for IVUS devices market, driven by increasing prevalence of cardiovascular diseases, improving healthcare infrastructure, and improved accessibility to modern intravascular ultrasound techniques.

In addition, the global market for intravascular ultrasound products report provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis, and market profitability analysis by key products and regions or countries. The report also tracks the major competitors operating in the global market by company overview, financial snapshot, major products, technologies, services offered and recent developments.

Major competitors operating in the global market for intravascular ultrasound devices and profiled in this report include Boston Scientific Corporation, Canon Medical Systems Corporation, Chison Medical Technologies Co., Ltd., Fujifilm Corporation, GE Healthcare, Hitachi Medical Corporation, Mindray Medical International Ltd., Philips Healthcare, Samsung Medison Co., Ltd., and Siemens Healthineers AG.

  • Modality
    • iMAP IVUS
    • Virtual Histology IVUS
    • Integrated Backscatter IVUS
  • Product
    • Consoles
    • Accessories
      • Catheters
      • Guidewires
      • Others
  • End User
    • Hospitals
    • Diagnostic Imaging Centers
    • Academic and Research Institutes
  • Geography
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Rest of the World
  • Company Profiles
    • Boston Scientific Corporation
    • Canon Medical Systems Corporation
    • Chison Medical Technologies Co., Ltd.
    • Fujifilm Corporation
    • GE Healthcare
    • Hitachi Medical Corporation
    • Mindray Medical International Ltd.
    • Philips Healthcare
    • Samsung Medison Co., Ltd.
    • Siemens Healthineers AG

To request Table of Contents and Sample Pages of this report:

Related publications:

    Request ToC/Sample information for this market analysis

    Full Name*

    Company Email*

    Phone Number* [Please add country code]



    Secure Online Payment

    iHealthcareAnalyst, Inc.

    Contact Address

    US Office: 2109, Mckelvey Hill Drive, Maryland Heights, MO 63043, United States
    Phone: +1 (314) 315-4764
    India Office: 5, Shilpa Chambers, Opp. J. M. Road, Shivajinager, Pune 411005, India
    Phone: +91 (20) 25898524
    Email: sales@ihealthcareanalyst.com